Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
30 April 2020updated 06 Oct 2020 9:45am

We’ll have “very good idea“ if Oxford vaccine works by July, says manufacturing lead

By Samuel Horti

The chief executive of pharmaceutical giant AstraZeneca, which has just been unveiled as a partner on the government-backed University of Oxford coronavirus vaccine trial, has said we’ll have a “very good idea” of the vaccine’s effectiveness by July.

The new partnership will see the company take responsibility for the “development and worldwide manufacturing and distribution of the vaccine”, ensuring that, if effective, it’s quickly handed out around the world.

Pascal Soriot told the BBC that “by June, July we will already have a very good idea of the direction of travel in terms of its potential efficacy”.

The research team, led by both the university’s Jenner Institute and the Oxford Vaccine Group, has previously said the vaccine could be ready as early as September. It is already testing the vaccine in humans, and hopes to test it in thousands of people next month.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy